Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Chinedu Simeon Aruah

Chinedu Simeon Aruah

National Hospital Abuja, Nigeria

Title: Anemia in cancer patients undergoing radiotherapy and chemotherapy in National Hospital Abuja, Nigeria

Biography

Biography: Chinedu Simeon Aruah

Abstract

Introduction: Many cancer patients present with anemia prior to radiotherapy and chemotherapy or may experience anemia/ worsening of anemia at some point during treatment. Aims & Objectives: The aim of the study was impact of anemia in cancer patients undergoing Radiotherapy and Chemotherapy. Methodology: 201 cancer patients of both sexes with histopathologically confirmed malignancies (solid cancers). Patient’s pretreatment Hb was taken. Patients were distributed into Radiotherapy, Chemotherapy and Chemoradiation. Their Hb was measured once every 2 weeks. The blood film pictures of the patients were examined. The whole process was terminated after 3 consecutive Hb reading or after week 6. Anemia was classified into: Less than 10 g/dl (Severe anemia), 10-10.9 g/dl(moderate anemia), 11-12 g/dl (mild anemia) and 12 g/dl and above (no anemia). Results & Analysis: Out of 201 cancer patients, 86.1% were female and 13.9% were male. Age range, 25-75 years, 100 patients were on Chemotherapy, 63 patients on Radiotherapy and 38 patients on Chemoradiation. The prevalence in anemia in cancer patients undergoing radiotherapy and chemotherapy was found to be 63% as shown by blood film picture (i.e., average of 72%, 42.9% and 73.7%). At the end of therapy, 62% (100) patients on Chemotherapy and 55.6% (63) patients on Radiotherapy had their Hb level between 11-12 g/dl, 39.5% (38) cancer patients on Chemoradiation arm had Hb value of 10-10.9 g/dl. At P-value>0.05, there was no statistical significance on distribution of mean Hb, standard deviation based on sex and treatment type. Conclusion: Prevalence of anemia in the study group was found to be 63% while 37% had adequate hemoglobin (Hb) after the therapy as reflected in the blood film picture. At 95% confidence interval, Chemotherapy had greatest impact on Hb level during therapy. Thus Chemotherapy: 9.60-10.62 g/dl, Radiotherapy: 11.52-12.13 g/dl and Chemoradiation therapy: 10.98-11.36 g/dl.

Speaker Presentations

Speaker PPTs Click Here